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Campylobacter coli are one of the most common bacteria in bacterial gastroenteritis and acute enterocolitis in
humans. However, relatively little is known regarding the mechanisms of pathogenesis and host response to C. coli
infections. To investigate the inﬂuence of genetic changes, we ﬁrst used PCR to demonstrate the presence of
the known virulence genes cadF, virB11, cdtB, cdtC and ceuE in the clinical isolate C. coli 26536, which was isolated from
the liver of infected BALB/c mice. Sequence analyses of the cadF, virB11, cdtB and ceuE genes in C. coli 26536 conﬁrmed
the stability in these virulence genes during their transmission through the host. We further investigated C. coli
infection for the bacterial clearance from the liver and spleen of infected mice, and for their immune response. C. coli
persisted well in both organs, with better survival in the liver. We also determined the levels of several pro-
inﬂammatory cytokines (i.e., interleukin [IL]-6, IL-12, interferon-g, tumor necrosis factor-a) and the anti-inﬂammatory
cytokine IL-10 in plasma and in liver homogenates from the infected mice, using enzyme-linked immunosorbent assays.
The lowest levels among these cytokines were for tumor necrosis factor-a in the plasma and IL-6 in the liver on days 1,
3 and 8 post-infection. The most pronounced production was for IL-10, in both plasma (days 1 and 8 post-infection) and
liver (day 8 post-infection), which suggests that it has a role in healing of the organ inﬂammation. Our ﬁndings showed
dynamic relationships between pro- and anti-inﬂammatory cytokines and thus contribute toward clariﬁcation of the
healing processes involved in the resolution of C. coli infections.
Introduction
Foodborne illnesses continue to present a public health chal-
lenge, and Campylobacter spp. represent the most common gas-
trointestinal bacterial pathogens in the European Union, where
infection rates continue to increase.1 Human infections with
Campylobacter spp most often arise as a direct result of consump-
tion of chicken products that have been contaminated during
processing2 and have not been cooked well enough. Intestinal
campylobacteriosis manifests as enteritis of the terminal part of
the ileum and colon. Patients can have mild to severe symptoms,
which commonly include watery, and sometimes bloody, diar-
rhea, and intense abdominal pain, fever, headache and nausea.
Infection is usually self-limiting and lasts only a few days.3
Although intestinal infection is rarely associated with a sys-
temic illness, extra-intestinal manifestations or post-infection
complications can occur, such as Guillain-Barre syndrome, glo-
merulonephritis, and reactive arthritis, especially in immuno-
compromised subjects.4 Both bacterial and host factors
contribute to the differences in the clinical manifestations of such
diseases in human.5 Campylobacter spp. have been reported to
have different virulence factors, such as for motility, bacterial
adherence to and invasion of epithelial cells, and production of
toxins.5-8 Several pathogenic genes are responsible for these viru-
lence properties, which include: cadF,9 which is responsible for
adherence and colony formation; virB11,10 which is responsible
for adherence and invasion; cdtB and cdtC,11-14 which are respon-
sible for toxin production and have additional roles in adherence
and invasion; and ceuE, which is responsible for hemolytic activ-
ity.15 However, it is well known that Campylobacter spp are natu-
rally competitive, and combined with their high rate of
recombination, this aspect can contribute to their genetic diver-
sity.16 Although high prevalence of some virulence and toxin
genes among Campylobacter spp. isolates has been noted, several
isolates also show wide variations in the presence of these patho-
genic genes.17,18 The mechanisms that induce this genetic diver-
sity in Campylobacter spp still remain poorly understood, and
thus the detection, and a better understanding of, these factors
will allow the definition of the virulence factors associated with
disease.18
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The interactions of Campylobacter spp. with intestinal epithe-
lial cells result in the production of cytokines, which are regula-
tors of host responses to infection, and which have important
roles in the pathogenesis of infectious diseases.19-21 Cytokines are
produced by immune cells, and according to their function, they
are divided into the pro-inflammatory cytokines, such as interleu-
kin (IL)-1, IL-2, IL-6, IL-8, IL-12, IL-17 and IL-18, tumor
necrosis factor (TNF)-a, and interferon (IFN)-g, and the anti-
inflammatory cytokines, such as IL-4, IL-10 and tumor growth
factor-b.2,22 Both pro-inflammatory and anti-inflammatory cyto-
kines are induced during Campylobacter spp infection, and it is
important to determine whether the immune system is successful
in providing protection against these specific pathogens.5 Some
cytokines can be produced in excess, and thus these might con-
tribute strongly to disease pathology.19 Indeed, it has been
reported that macrophages produce IL-1a, IL-1b, IL-6, IL-8 and
TNF-a when infected with Campylobacter spp..23 However, the
pathogenesis of C. coli infection is still poorly understood, which
is mainly a consequence of the lack of a suitable animal model
that can be used to mimic the course of infection in human.24
We thus monitored the stability of the virulence and toxin
genes (i.e., cadF, virB11, cdtB, cdtC, ceuE) by comparing the
sequence data of C. coli 26536 before and after transmission
through the host, and their colonisation and cytokine induction
in a murine model. In previous studies, we showed that C. jejuni
can successfully invade epithelial cells in vitro8,40 and produce
systemic infection in vivo.25 Our earlier data obtained in vitro
showed that C. jejuni can survive both in phagocytes (for 72 h)
and in intestinal epithelial cells (for 96 h). This is in agreement
with the conclusions of Day et al. (2000),41 who considered
C. jejuni to be a facultative intracellular pathogen, and not a typi-
cal extracellular bacterium.
In the present study, we focused on the clearance from the
liver and spleen of BALB/c mice infected with the C. coli 26536
clinical isolate, and the association between systemic and local
cytokine responses following C. coli dissemination. The levels of
several pro-inflammatory cytokines (i.e., IL-6, IL-12, TNF-a,
IFN-g) and one anti-inflammatory cytokine (i.e., IL-10) in
plasma and liver homogenates were determined on days 1, 3 and
8 post-infection, using enzyme-linked immunosorbent assays. As
the cytokine network is one of the main controlling elements in
the inflammation process, we wanted to determine any correla-
tion between cytokine production and course of infection.
Results
Presence of virulence genes in C. coli
The presence of the cadF, virB11, cdtB, cdtC and ceuE viru-
lence genes in C. coli 26536 was analyzed using polymerase chain
reaction (PCR) (Table 1). Of these, the cdtC gene was not
detected in the C. coli 26536 strain (Table 2). Furthermore, we
analyzed the stability of these genes by sequencing of the viru-
lence genes cadF, virB11, cdtB and ceuE in C. coli 26536 after
transmission through the mice. These examinations of the DNA
sequence data of each of these individual genes allowed
comparisons of the analyzed gene sequences in C. coli 26536
obtained after 48 h of cultivation on Columbia selective agar in a
microaerobic atmosphere at 42C, and in C. coli 26536 isolated
from the spleen of infected BALB/c mice. We confirmed the sta-
bility of the tested cadF, virB11, cdtB and ceuE genes in C. coli
26536 (Table 2).
Survival of C. coli 26536 in the livers and spleens
of infected mice
BALB/c mice were infected intravenously with C. coli 26536
and the course of infection was monitored over 8 days, in terms
of the bacterial colony forming units (CFU) in the livers and
spleens of the infected mice. Infected mice did not show signs of
diarrhea, but they were lethargic with bristled fur, and they
appeared not to be in good health (e.g., also showing lack of
appetite and shaking). On days 1, 3 and 8 post-infection, the
mice were sacrificed and the culturability of the bacteria from
their livers and spleens was determined.
On day 3 post-infection, the livers of infected mice were
enlarged and yellowish nodes were noted (Fig. 1). Microscopic
examination of haematoxylin and eosin stained sections showed
local tissue necroses and inflammatory infiltration, with neutro-
phils and rare plasma cells in the surrounding tissue, although
bacteria could not be seen. These macroscopic liver changes were
more prominent than those of the spleen. However, C. coli
26536 was detected in both livers and spleens of the infected
mice through the entire experimental period (Fig. 2), although
the growth patterns differed. At each time point, the CFU of
C. coli 26536 isolated from the spleen was significantly lower
than the CFU of C. coli 26536 recovered from the liver (P <
0.005). C. coli 26536 reached their maximal CFU in the liver on
day 1 post-infection, which then slowly, but significantly,
decreased through day 3 to day 8 post-infection (P < 0.05). In
contrast,
C. coli 26536 CFU in the spleen increased significantly through
day 3 to day 8 post-infection (P< 0.05), which was the last mon-
itored day of infection in the present study. Kupffer cells in the
liver and macrophages, and other phagocytic cells in the spleen,
appeared to provide a reservoir where C. coli survived for some
time, and consequently were isolated from these organs up to day
8 post-infection.
Levels of different cytokines in the plasma and liver during
C. coli 26536 infection of mice
The impact of C. coli 26536 on systemic cytokine production
and in the liver of infected mice was studied, in comparison with
the cytokine production patterns in the plasma and liver of
non-infected mice. We determined the concentrations of the
pro-inflammatory IL-6, IL-12, TNF-a and IFN-g, and the anti-
inflammatory IL-10, in the plasma and in liver homogenates on
days 1, 3 and 8 post-infection (Fig. 3).
When the mice were infected with C. coli 26536, the levels
and the dynamics of the production of these investigated cyto-
kines differed. The differences in the concentrations of IL-6 and
TNF-a in the plasma between the infected and control mice
were minimal throughout the experimental period. TNF-a in
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the plasma remained at about 22 pg/mL and IL-6 at about 100
pg/mL. On days 1 and 3 post-infection, the levels of IL-12 in the
plasma tended to be lower in the infected mice than in the con-
trol mice, but by day 8 post-infection, IL-12 in the plasma was
higher in the infected mice than in the control mice. However,
for the plasma levels of the cytokines, on day 3 post-infection
there were also significant differences between the mice infected
with C. coli 26536 and the control mice, with IFN-g significantly
higher in the infected mice (Fig. 3A). At the same time, although
the concentrations of IL-10 in the plasma of the infected mice
were higher than in the control mice, these differences did not
reach significance.
Different cytokine production patterns were revealed in the
liver of the mice infected with C. coli 26536, as can be seen in
Figure 3B. Here, when IL-10 was analyzed, there were marked
differences between the infected and control mice through the
entire period of infection. The concentrations of IL-10 in the
liver showed an increasing trend, and reached the highest values
on day 8 post-infection. In addition, there was a pronounced dif-
ference between the infected mice and the control mice for TNF-
a production in the liver that was already apparent on day 1 of
infection. By the last day of infection, day 8, this TNF-a concen-
tration had dropped, and it was slightly lower in the infected
mice compared to the control mice, although this difference was
not significant. The differences in IL-6 production in the liver
between the infected and control mice were minimal throughout
the entire infection period, at around 50 pg/mL to 100 pg/mL in
the infected and control mice, and these differences did not reach
significance. Furthermore, no significant differences were seen
between the infected mice and the control mice for IFN-g in the
liver. These results clearly show different cytokine patterns
between systemic and local cytokine production during infection,
probably linked to the repair of damage to the affected organs.
Discussion
The prevalence of intestinal campylobacteriosis is very high in
developed countries, and this represents a great burden for public
healthcare systems.1 Despite this, the pathogenesis of campylo-
bacteriosis is still not completely understood for infections with
both C. jejuni and, in particular, C. coli, although infections with
C. coli are less frequent than those with C. jejuni. Most cases of
campylobacteriosis are associated with eating raw or undercooked
contaminated poultry or pork meat, or from cross-contamination
of other foods by these items.28 Comparisons of pulsed-field gel
electrophoresis and virulence profiles have shown high genetic
diversity of the different strains examined, which leads us to
Table 1. PCR primer pairs and conditions32
Target Primer pair n-mer Sequence (50–30) Amplication size (bp) PCR conditions Reference
cadF F2B 20 TGG AGG GTA ATT TAG ATA TG 400 94C, 1 min Konkel et al., 1999
R1B 20 CTA ATA CCT AAA GTT GAA AC 45C, 1 min (30 cycles)
72C, 3 min
virB11 virB11 23 GAA CAG GAA GTG GAA AAA CTA GC 708 95C, 2 min Bacon et al., 2000
virBR 21 TTC CGC ATT GGG CTA TAT G 95C, 30 s
52C, 30 s (35 cycles)
72C, 2 min
cdtB VAT2 24 GTT AAA ATC CCC TGC TAT CAA CCA 495 94C, 1 min Pickett et al., 1996
WMI-R 24 GTT GGC ACT TGG AAT TTG CAA GGC 42C, 2 min (30 cycles)
72C, 3 min
cdtC WMI-F 24 TGG ATG ATA GCA GGG GAT TTT AAC 555 94C, 1 min Pickett et al., 1996
LPF-X 24 GTT GGC ACT TGG AAT TTG CAA GGC 42C, 2 min (30 cycles)
72C, 3 min
ceuE COL1 24 ATG AAA AAA TAT TTA GTT TTT GCA 894 95C, 30 s Gonzales et al., 1997
COL2 21 ATT TTA TTA TTT GTA GCA GCG 57C, 30 s (30 cycles)
72C, 1 min
Table 2. Target genes and GenBank accession numbers of the C. coli 23536 isolate
C. coli 26536
Virulence properties Target gene Isolate from ¡80C
Isolate from infected
mouse liver
GenBank accession
No.
Adherence, colonisation cadF X X KJ875966
Adherence, invasion virB11 X X KJ875960
Adherence, invasion, CDT toxin cdtB X X KJ875957
Adherence, invasion, CDT toxin cdtC ND ND /
Hemolytic activity ceuE X X KJ875961
X, gene present; ND, gene not detected.
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believe that there can be different degrees of pathogenicity within
any given Campylobacter spp population.29
More specifically considering the virulence mechanisms for
the pathogenesis of Campylobacter spp. during human infections,
these might contribute to their flagella-mediated motility, adher-
ence to the intestinal mucosa, invasive capability, and production
of toxins.6,7 Indeed, several potential virulence factors have been
identified11,13-15,23 that show different prevalence according to
the human, animal or environmental sources of the Campylobac-
ter spp strain.18,30-32 One of these is the cadF gene, which enco-
des a protein belonging to the group of outer-membrane proteins
that facilitates the binding of Campylobacter spp. in the host
cells,33 as was confirmed by Campylobacter spp colonisation using
a chicken model.34 Another virulence gene linked with
Campylobacter spp. invasiveness is the invasion-associated marker
virB11 gene, which is associated preferentially with both bacterial
adherence and invasion.10 Campylobacter spp can also secrete a
toxin known as cytolethal distending toxin (CDT), which is a
complex of the ctd gene products CdtA, CdtB and CdtC. These
three subunits act together to block cell division through cell-
cycle arrest, and all 3 are necessary for the cytotoxin activity that
is known to be lethal for host enterocytes.11,12 The ceuE gene
encodes a lipoprotein component of a binding-protein-depen-
dent transport system for the siderophore enterochelin.35 Iron
acquisition is a crucial aspect of bacterial infectivity, and it has
been suggested that this system has an important role in bacterial
virulence.
In the present study, we initially investigated the presence of
the cadF, virB11, cdtB, cdtC and ceuE genes in the C. coli 26536
clinical isolate using PCR. In this way, we confirmed the presence
of the cadF, virB11, cdtB and ceuE genes, but not of the cdtC
gene, in this C. coli 26536 isolate. Analysis of the cadF gene has
revealed its high prevalence (i.e., 100%) among Campylobacter
spp. isolates derived from poultry carcasses, broiler faeces, bovine
faeces, retail raw meat, pig and cattle,18,30-32,36 and also among
isolates of human origin.30,31,37 The cadF gene is probably con-
served among Campylobacter spp isolates,18 regardless of their
origin or species, as is the case also in the C. coli 26536 isolate
used here. In contrast, several studies have shown wide variations
for the presence of virB11, which was not found in C. jejuni and
C. coli isolates from poultry faeces,18 although it was identified in
4% to 15% of isolates tested from poultry meat, pig and cat-
tle,31,32,36 and in 10% to 17% of human clinical samples.31,38
However, the prevalence of the plasmid pVir appears to be simi-
lar among poultry and human isolates.17,31,38 The production of
the pVir plasmid genes in the C. coli 26536 clinical isolate used
in the present study thus indicates the possibility of severe inva-
sive infection.
Figure 1. Liver from a BALB/c mouse on day 3 post intravenous infection
with 0.5–1.0 £ 109 CFU C. coli 26536. Macroscopic (A) and microscopic
examination of haematoxylin and eosin stained liver section (B). Arrows,
local tissue necrosis. Bar, 500 mm.
Figure 2. Survival of C. coli 26536 in the liver and spleen (as indicated) of
mice infected intravenously with 0.5–1.0 £ 109 CFU C. coli 26536. At
each indicated time, the mice were sacriﬁced, and the number of bacte-
ria per organ was determined using the CFU assay. Each point represents
the log10 of the median value § standard deviation, as CFU/organ
(* P  0.05).
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In recent studies, the distribution and prevalence of the CDT
gene cluster of the cdtA, cdtB and cdtC genes in C. jejuni and
C. coli isolates was investigated, and these genes were found in
different ratios.30,32 The genes encoding the cdt gene cluster are
widespread among poultry and human Campylobacter
spp. isolates, with the cdtC gene showing higher prevalence
among C. jejuni strains (93%–100%) than for C. coli (66%–
100%), and with similar cdtB gene prevalence for both C. jejuni
and C. coli (91%–100%).18,32,36,37 The absence of the PCR
product of the cdtC gene in the clinical C. coli isolate in the
Figure 3. Differences from the control mice of the median cytokine levels (as indicated) in the plasma (A) and liver (B) of mice infected with C. coli 26536.
Median control levels represent zero on the Y axis. Each bar represents the difference between the values for the infected mice minus those for the con-
trol mice, at each time point (as indicated) (* P < 0.05). Error bars represent ranges (maximum or minimum test value minus median control value). Cyto-
kine levels in control mice were as follows: (A) plasma: IL-6, 12.83 pg/mL; IL-12, 1529.5 pg/mL; TNF-a, 27.61 pg/mL; IFN-g, 42.84 pg/mL; IL-10, 37 pg/mL.
(B) liver: IL-6, 853 pg/mL; IL-12, 1659.5 pg/mL; TNF-a, 14445 pg/mL; IFN-g, 3300 pg/mL; IL-10, 1637.8 pg/mL.
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present study is similar to data from previous studies, where C.
jejuni can produce much higher levels of CDT in comparison to
C. coli. The functional toxin is a tripartite complex in which
CdtB is the active subunit that has an intrinsic DNase-I–like
activity, while the CdtA and CdtC subunits are required for the
delivery of CdtB into the host cell.7,11-13 Furthermore, the inter-
actions of CdtA, CdtB and CdtC are necessary to form an active
tripartite holotoxin that has full cellular toxicity.12 Hence, the
absence of the cdtC gene indicates that C. coli 26536 cannot pro-
duce a fully active CDT toxin. The ceuE gene encodes a lipopro-
tein, and this has been detected in all Campylobacter spp
isolates,32 and was also present in the clinical C. coli 26536 isolate
in the present study, thus confirming the high prevalence of this
virulence factor.
As determined above, studies of the prevalence of these viru-
lence genes in isolates from various sources are essential to pro-
vide more information on the hazards of the Campylobacter spp.
that might be circulating. As different determinants can influence
the characteristics of these virulence determinants,39 we also fol-
lowed the stability of the cadF, virB11, cdtB and ceuE genes that
we detected in C. coli 26536 after transmission through a host.
Here, we infected BALB/c mice with C. coli 26536 and then we
collected the isolate from the spleen of the infected mice from
day 3 post-infection. Each of the cadF, virB11, cdtB and ceuE
genes was detected by PCR in isolates after storage conditions at
¡80C, and again in isolates from the livers of these infected
mice. Interestingly, all of these virulence genes were maintained
in the C. coli isolates after the imitation food chain and after the
transmission through the host mouse model. We further fol-
lowed the stability in the cadF, virB11, cdtB and ceuE genes by
comparing the sequence data for the isolates obtained through
the imitation transition route using transmission through the
host model. These sequence analyses showed that the sequence
data of the virulence and toxin genes cadF, virB11, cdtB and ceuE
remained the same in both of these isolates, and thus these genes
were conserved through the transmission through the host, which
supports their involvement in the virulence process.
It is well known that innate immunity is the first line of
defense against microbial infection, and that this is required for
the removal of the pathogen from the host.42,43 For colonisation
and cytokine induction, we used the experimental model of
murine campylobacteriosis, which has been adopted for the study
of systemic infection and dissemination of Campylobacter spp,
and the pathogenesis of Campylobacter spp. infection.25-27 We
thus followed the systemic spread and infection for the internal
organs (i.e., liver, spleen) after intravenous infection of BALB/c
mice with this human clinical isolate of C. coli. We followed the
course of infection and cytokine production.
After intravenous inoculation, C. coli 26536 established both
liver and spleen infections, with better survival in the liver than
the spleen of these infected mice. The CFU of C. coli isolated
from the liver of the infected mice on day 8 post-infection was
significantly lower in comparison to days 1 and 3 post-infection.
This falling pattern of bacterial numbers isolated from the liver
has also been seen previously in the liver of mice infected with C.
jejuni.44 In contrast, the CFU of C. coli isolated from the spleen
of the infected mice in the present study was increasing toward
the last day post-infection (day 8). This might be explained by
the potentially lower number of macrophages in the liver.
Kupffer cells in the liver and macrophages and other cells in the
spleen (i.e., neutrophils, eosinophils, monocytes) also have
phagocytic functions.45 It has been shown that any prolongation
of bacterial survival in macrophages increases the probability of
their transmission within the host organism, and this has further
implications in the pathogenesis of campylobacteriosis.46,47 Thus
these cells might represent a reservoir, whereby the Campylobacter
spp can survive for some time after intravenous inoculation in an
experimental animal, which might be why C. coli was still isolated
from the selected organs at day 8 post-infection.
During a systemic bacterial infection, numerous pro-inflam-
matory cytokines are produced, and their blood levels are ele-
vated, although this greatly depends on the microbial
characteristics and structure.43 Furthermore, the immune func-
tions of cytokines result from the coordinated action of T cells,
macrophages and dendritic cells, and these largely depend on the
recruitment of these calls to the sites of infection and inflamma-
tion, and to other pathological lesions.48 Previously, Hu et al.
(2006)49 demonstrated that C. jejuni infection can trigger innate
inflammatory responses, and induce human dendritic cell matu-
ration and production of pro-inflammatory cytokines, including
IL-6, IL-8, IL-12 and TNF-a. In this way, cytokines can induce
Campylobacter-specific Th1 effector-cell responses, and contrib-
ute to the pathogenesis and clinical symptoms of Campylobacter
spp. infection. However, the molecular mechanisms underlying
the dendritic-cell-mediated induction of adaptive immune
responses to C. jejuni are not known.50 Interestingly, in the pres-
ent study, the numbers of bacteria infecting the liver and spleen
did not completely correlate with the cytokine profiles in the
plasma and liver. Pro-inflammatory cytokines persisted during
the whole infection period, both in the plasma and the liver,
although C. coli 26536 did not provoke the production of IFN-g
in the liver, and there was only weak production of IL-12. In
addition, high TNF-a production on day 1 post-infection was
accompanied by the lowest production of the anti-inflammatory
IL-10 in the liver of the infected mice, although not in their
plasma.
The spectrum of cytokines in the plasma did not completely
correlate with the cytokine profile in the liver. In plasma, for
example, the levels of TNF-a were similar to those in the control,
non-infected, mice during the whole period of infection, but in
the liver, TNF-a peaked on day 1 post-infection and then
dropped to even below the level of TNF-a in the control mice.
Previous studies have demonstrated central roles for IFN-g, IL-1
and TNF-a in inflammatory reactions, which can lead to the
eradication of obligate and facultative intracellular patho-
gens.51,52 TNF-a has been shown to have a role in limiting the
severity of bacterial infections through various mechanisms,
which include the selective killing of cells that harbour bacteria,
activation of monocytes and granulocytes, and stimulation of
specific immune responses. Particularly in infections with faculta-
tive intracellular bacteria, anti-TNF-a antibody treatment pro-
moted massive proliferation of the infecting organisms. These
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data suggest that the ability to inhibit TNF-a is advantageous to
the pathogen.53 Unexpectedly, in the present study, C. coli did
not show this effect: in spite of the extremely low concentrations
of TNF-a in the liver of infected mice on day 8 post-infection,
the number of C. coli isolated also dropped.
Overall, following the infections with C. coli, the levels of IL-6
for both the plasma and the liver of the infected mice were almost
the same as in the control mice during the entire course of the
infection. Infection of the mice with C. coli 26536 provoked the
greatest production of IFN-g in the plasma on day 3 post-infec-
tion. IFN-g is known to enhance major histocompatibility com-
plex class I and II expression on nucleated cells and to stimulate
many effector functions of mononuclear phagocytes. In addition,
IFN-g induces the expression of many adhesion proteins on the
vascular endothelium, to potentiate the function of TNF-a and
to promote T-lymphocyte infiltration at sites of infection. For
this reason, these high levels of TNF-a in the liver at the begin-
ning of the infection and IFN-g in the plasma might indicate the
activation of macrophages and Th1 cells.5 Our data show time-
dependent secretion of IL-12 and an increase in IL-12 produc-
tion toward day 8 post-infection in the plasma of the infected
mice. Secreted IL-12 can enhance CD4C T-cell proliferation and
IFN-g production, although this was not seen here. In addition,
recent studies have shown that IL-12 mediates dendritic cell acti-
vation of natural killer cells, and in this way contributes to initial
resistance to bacterial pathogens, and also controls reinfection of
C. jejuni in mice.54-56 High levels of production of IL-12 initiate
a Th1 polarized adaptive immune response.49
Interleukin-10 functions as an anti-inflammatory cytokine,
and it is known to suppress production of pro-inflammatory
cytokines such as IL-12, TNF-a and IFN-g. In addition, its rela-
tionship with some pro-inflammatory cytokines is important for
the outcome of infection and sepsis.48 In the present study, the
first cytokine that began to rise in the liver of the infected mice
was IL-10. C. coli 26536 induced the strongest anti-inflammatory
IL-10 response in the liver by the last day of infection (day 8). As
indicated above, there was an early rise in TNF-a in the liver,
which is as expected, as TNF-a is a prerequisite for the produc-
tion of other pro-inflammatory cytokines. On the other hand, an
early increase in IL-10 is hard to explain, especially as it occurred
simultaneously with the rise in the pro-inflammatory cytokines,
as seen in the liver of the infected mice. This will need further
investigation for a systematic explanation. However, this simulta-
neous production of both pro-inflammatory and anti-inflamma-
tory cytokines has also been demonstrated in an in-vitro cell
culture model of the INT407 human intestinal cell line.57
In conclusion, along with C. jejuni, C. coli are one of the
most common bacteria that cause bacterial gastroenteritis and
acute enterocolitis in human in developed countries. Despite its
obvious global importance, relatively little is known regarding
the mechanisms of pathogenesis and host response to C. coli
infection. In the present study, we have confirmed the presence
of the cadF, virB11, cdtB and ceuE virulence genes in this C. coli
26536 isolate, and we monitored the stable virulence and toxin
genes following C. coli transmission through a host, as such dif-
ferences might influence Campylobacter spp colonisation and
cytokine induction in an in-vivo model. Furthermore, we used
our previously established experimental model of systemic cam-
pylobacteriosis in mice. In this way, we followed the course of
infection and cytokine production after intravenous challenge of
BALB/c mice with this human clinical C. coli 26536 isolate. The
levels of several pro-inflammatory cytokines (IL-6, IL-12, TNF-
a, IFN-g) and one anti-inflammatory cytokine (IL-10) in plasma
and liver homogenate were determined on days 1, 3 and 8 post-
infection using enzyme-linked immunosorbent assays. The
C. coli produced systemic infection in these immunocompetent
BALB/c mice, but did not induce production of the pro-inflam-
matory cytokine IL-6, either in the plasma or in the liver of the
infected mice. In contrast, in these infected mice, the anti-inflam-
matory cytokine IL-10 showed markedly greater production in
the liver, with dynamics that correlated with the declining num-
ber of C. coli in the liver. It is well known that the cytokine net-
work is one of the main controlling elements in the
inflammation and immune reactions that occur during bacterial
infection. Dynamic relationships between pro- and anti-inflam-
matory cytokines, their rates of production, and their levels in
different tissues are among the variables in the control of healing
processes and the resolution of infections. Thus, it is important
to determine any correlations between cytokine production and
the course of infection. Here, our investigations have contributed
further toward the clarification of these relationships.
Materials and Methods
Bacterial isolate
The C. coli 26536 clinical isolate was provided by the Labora-
tory for Diagnostics of Enteric Infections of the Teaching Insti-
tute of Public Health of the Primorsko-Goranska county,
Croatia, and was previously characterized.58 The isolate was then
stored at ¡80C in brain–heart infusion broth supplemented
with blood (5%, Oxoid, SR0048) and glycerol (10%, Kemika,
0709704) until use, and cultured using microaerobic growth
(5% O2, 10% CO2, 85% N2) in Preston broth (Oxoid,
CM0689) at 42C.59
Virulence genes and sequence analysis
The cadF gene encodes adhesin, which is responsible for cer-
tain steps in cell invasion, while the virB11 gene is a marker for
the pVir plasmid, the cdtB and cdtC genes are involved in CDT
production, and the ceuE gene encodes a lipoprotein that is asso-
ciated with haemolysins. These five genes were assessed using
PCR. For the present analysis using PCR and for the sequence
analysis, we used C. coli 26536 revitalised on Columbia selective
agar (Oxoid, CM0331), after storage at ¡80C. This isolate was
further used to infect BALB/c mice, and then recovered from the
mouse spleen on day 3 post-infection.
The primer sequences of the virulence and toxin genes, the
expected sizes of their products, and the cycling conditions for
the determination of the presence of these 5 putative virulence
factors cadF, virB11, cdtB, cdtC and ceuE of C. coli are listed in
Table 1. Bacterial DNA was extracted using the PrepMan Ultra
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sample preparation reagent (Life Technologies, 4318930), fol-
lowing the manufacturer recommendations, and the extracted
DNA preparations were stored at ¡20C. PCR amplifications
were performed in 50 mL reaction volumes that contained 10£
RED Taq PCR buffer (Sigma-Aldrich GmbH, B5926), 20 mM
dNTP (Life Technologies, N8080007), 300 nM forward primer,
300 nM reverse primer (Table 1), 1 U/mL RED Taq polymerase
(Sigma-Aldrich GmbH, D4309), and 5 mL DNA lysate. The
PCR was performed in a thermal cycler PCR system (2400
GeneAmp; Perkin Elmer). The cycling conditions varied accord-
ing to the specific gene determination (Table 1). The PCR prod-
ucts were electrophoresed on 2% agarose gels. The virulence
genes cdtB, virB11, cadF and ceuE of C. coli were further investi-
gated by sequence analysis (Macrogen), to study the genetic dif-
ferences of this C. coli isolate following the storage conditions,
after sub-cultivation in the food model, and after isolation from
the infected mice. The sequences of cdtB, cdtC, cadF and ceuE
have been deposited in GenBank, with their accession numbers
given in Table 2.
C. coli 26536 infection in mice
Eight to 12-week-old BALB/c (H-2d) mice were obtained
from the Central Animal Facility of the Medical Faculty, Univer-
sity of Rijeka, and the experiments were conducted according to
the Guidelines of the International Guiding Principles for Bio-
medical Research Involving Animals (NCR, 2004). The Ethical
Committee of the University of Rijeka approved all of the animal
experiments described here.
The mice were given standard laboratory rodent food
(Mucedola, 4RF21GLP) and water ad libitum. They were
infected intravenously via the lateral tail vein with a single
dose (200 mL) of 0.5–1.0 £ 109 CFU C. coli 26536 cells, as
determined by the turbidity of the bacterial suspension and
confirmed retrospectively by plating the inoculum on blood
agar and incubating them microaerobically for 48 h at 42C.
On days 1, 3 and 8 post-infection, the mice were anaesthe-
tised with sodium pentobarbital and sacrificed, and their liv-
ers and spleens were removed aseptically. The C. coli 26536
CFU in these organs were determined as previously
described.25 At least 6 mice per time point were infected. For
organ burden determination, at least 3 mice were sacrificed
per time point, and at least another 3 for cytokine analyses.
All of the experiments were repeated 3 times and the data
from all of the replicate experiments were pooled and are pre-
sented as means § standard deviation.
Cytokine analysis
For the determination of the cytokine concentrations, mice
were anaesthetised with sodium pentobarbital and sacrificed, with
their blood collected in sterile vials (Eppendorf AG, 00298–00)
that contained ethylendiamine tetra-acetic acid. The tubes were
centrifuged, and the plasma was separated and stored at ¡20C
until assayed. The livers of these mice were removed aseptically,
dissected from the surrounding tissue, and collected on ice in
preweighed sterile vials (Eppendorf AG). The weights of the liv-
ers were recorded using an electronic balance (PB602-S). The liv-
ers were then frozen in liquid nitrogen, and stored at ¡80C.
The livers were homogenized and the organ supernatants
collected as previously described.44 Briefly, immediately
before analysis, the livers were thawed on ice and homoge-
nized in ice-cold phosphate-buffered saline (5 mL per 1 g tis-
sue, wet weight) using a hand-held tissue homogenizer.
Following homogenization, the liver samples were centrifuged
(14,000 £ g, 10 min, 4C) to precipitate the cell debris as a
pellet. These supernatants were stored at ¡20C until they
were assayed for cytokine levels. The levels of IL-6, IL-10,
IL-12, TNF-a and IFN-g were determined in duplicate,
using mouse cytokine enzyme-linked immunosorbent assay
kits (Thermo Scientific, EM2IL6, EM2IL10, EMIL12TOT2,
EMTNFA5, ESS0020), and the data are expressed in pg/mL
plasma or tissue homogenate, as described previously.44 The
sensitivity levels were: IL-6, 7 pg/mL; IL-10, 12 pg/mL;
TNF-a, 9 pg/mL; and IFN-g, 10 pg/mL. Control mice of
the same age and sex were injected with sterile saline. All of
the experiments were independently repeated 3 times, and
the data are presented as means § standard deviation.
Statistical analysis
The differences for the CFU in the organs and the cytokine
levels in the plasma and liver homogenates were calculated using
Kruskal Wallis tests. Mann Whitney tests were used to verify dif-
ferences between pairs of groups. Differences were considered
significant at the P level of 0.05. Statistical analysis was
performed using SPSS 15.0 for Windows (Statsoft Inc.).
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